Pharmaron Beijing Co., Ltd. (SHE:300759)
China · Delayed Price · Currency is CNY 29.36
-0.55 (-1.84%)
Dec 15, 2025, 10:51 AM CST
Pharmaron Beijing Market Cap
Pharmaron Beijing has a market cap or net worth of 50.14 billion as of December 12, 2025. Its market cap has increased by 12.57% in one year.
Market Cap
50.14B
Enterprise Value
54.81B
Revenue
13.54B
Ranking
n/a
PE Ratio
34.94
Stock Price
29.36
Market Cap Chart
Since January 28, 2019, Pharmaron Beijing's market cap has increased from 7.24B to 50.14B, an increase of 592.59%. That is a compound annual growth rate of 32.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 12, 2025 | 50.14B | 19.81% |
| Dec 31, 2024 | 41.85B | -11.66% |
| Dec 29, 2023 | 47.37B | -38.44% |
| Dec 30, 2022 | 76.95B | -27.67% |
| Dec 31, 2021 | 106.40B | 12.84% |
| Dec 31, 2020 | 94.29B | 140.25% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jan 28, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Pharmaceuticals Co.,Ltd | 419.80B |
| WuXi AppTec | 279.36B |
| Shenzhen Mindray Bio-Medical Electronics | 241.66B |
| Sichuan Biokin Pharmaceutical | 148.61B |
| Shanghai United Imaging Healthcare | 105.48B |
| Aier Eye Hospital Group | 103.27B |
| Zhangzhou Pientzehuang Pharmaceutical., | 103.09B |
| Yunnan Baiyao Group Co.,Ltd | 99.62B |